Researchers at UW–Madison have engineered silicone nanoparticles to cross the blood-brain barrier in mice to deliver brain-wide gene editing therapy for Alzheimer’s disease.
Researchers at UW–Madison have engineered silicone nanoparticles to cross the blood-brain barrier in mice to deliver brain-wide gene editing therapy for Alzheimer’s disease.